|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine, Division of Cardiology, Emory University, Atlanta, Georgia, United States
2 Medicine, Division of Cardiology, Emory University, Atlanta, Georgia, United States; , United States
* To whom correspondence should be addressed. E-mail: kgriend{at}emory.edu.
Vascular diseases are a major complication of diabetes mellitus (DM), although their etiology is poorly understood. NADPH oxidase-derived reactive oxygen species (ROS) production and inflammation are potential mediators of DM-associated vascular diseases. Using db/db mice as a type 2 diabetes model, we examined the relationship between NADPH oxidase-derived ROS and vascular inflammation. Compared with control m+/+ mice, aortas from 4- and 12-week-old db/db mice had higher NADPH oxidase activity and increased superoxide levels, leading to NADPH oxidase-dependent impaired vasodilation at 12 weeks. Diabetes progression from 4-12 weeks led to increased Nox1, Nox4 and p22phox subunit mRNAs, and induced the expression of a group of matrix remodeling-related cytokines; connective tissue growth factor (CTGF), bone morphogenetic protein 4 (BMP4) and osteopontin (OPN). After 8 weeks of treatment with the superoxide scavenger tempol, 12-week db/db mice had lower superoxide production, reduced plasma glucose and lipids, and lower BMP4 and OPN protein expression compared with non-treated mice. No changes were observed with tempol in CTGF or m+/+ mice. The ability of tempol to reverse ROS production as well as OPN and BMP4, but not CTGF, induction suggests that DM-induced vascular inflammation involves both ROS-sensitive and -insensitive pathways.
This article has been cited by other articles:
![]() |
A. Csiszar, N. Labinskyy, H. Jo, P. Ballabh, and Z. Ungvari Differential proinflammatory and prooxidant effects of bone morphogenetic protein-4 in coronary and pulmonary arterial endothelial cells Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H569 - H577. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Paravicini and R. M. Touyz NADPH Oxidases, Reactive Oxygen Species, and Hypertension: Clinical implications and therapeutic possibilities Diabetes Care, February 1, 2008; 31(Supplement_2): S170 - S180. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Mundy, E. Haas, I. Bhattacharya, C. C. Widmer, M. Kretz, K. Baumann, and M. Barton Endothelin stimulates vascular hydroxyl radical formation: effect of obesity Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2218 - R2224. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. SHAO, Z. A. ALY, C.-F. LAI, S.-L. CHENG, J. CAI, E. HUANG, A. BEHRMANN, and D. A. TOWLER Vascular Bmp Msx2 Wnt Signaling and Oxidative Stress in Arterial Calcification Ann. N.Y. Acad. Sci., November 1, 2007; 1117(1): 40 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Miller, W. C. Watson, K. A. Kerr, C. A. Labarrere, N. X. Chen, M. A. Deeg, and J. L. Unthank Development of progressive aortic vasculopathy in a rat model of aging Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2634 - H2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rajesh, P. Mukhopadhyay, S. Batkai, G. Hasko, L. Liaudet, V. R. Drel, I. G. Obrosova, and P. Pacher Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H610 - H619. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |